MT3 and Alzheimer disease: Indeed, MT3 shows abnormal expression in each lesion in patients with Alzheimer’s disease (AD) as confirmed by immunohistochemistry, Northern blotting, and reverse transcription polymerase chain reaction (RT-PCR) [7, 61].